Product Quantum (Rs. Cr) Long Term Rating Short Term Rating
Bank Loan Ratings 54.00 ACUITE BBB | Stable | Reaffirmed -
Bank Loan Ratings 106.00 - ACUITE A2 | Reaffirmed
Total Outstanding 160.00 - -
Total Withdrawn 0.00 - -
 
Rating Rationale

­Acuité ­has reaffirmed its long-term rating of 'ACUITE BBB' (read as ACUITE triple B) and its short term rating of 'ACUITE A2' (read as ACUITE A two) on the Rs.160.00 crore bank facilities of Spectrum Ethers Private Limited (SEPL). The outlook is ‘Stable’.

Rationale for Rating Reaffirmation
The rating reaffirmation considers SEPL’s improved operating performance in FY2025 and healthy financial risk profile. The rating further continues to factor in the extensive experience of SEPL’s promoters of over three decades in the agrochemical industry. However, the rating remains constrained on account of intensive nature of working capital operations and SEPL’s exposure to agro-climatic fluctuations.


About the Company
­Incorporated in 1993, Spectrum Ethers Private Limited is engaged in manufacturing of agrochemicals and is based out of Nashik, Maharashtra. The key products of the company are Profenofous Tech, Propiconazole Tech,Turbofous Tech and others. The directors of the company are Dr. Milind Shankarrao Kolhe, Shri. Jugalkishore Ganpatlalji Agrawal, Shri. Arun Gangadhar Daware and Shri. Chandrashekhar Vitthalrao Joshi.
 
Unsupported Rating
­Not Applicable
 
Analytical Approach
­Acuité has considered the standalone business and financial risk profile of SEPL to arrive at this rating.
 
Key Rating Drivers

Strengths

­Established track record along with experienced management
Incorporated in 1993, SEPL has an established track record of operation of over 30 years in manufacturing of agrochemicals. The extensive experience of the management has helped the company to forge longstanding relationship with its customers and suppliers.

Acuite believes that SEPL will continue to benefit from its experienced management and a longstanding relationship with reputed clientele.

Improvement in the revenue and profitability as compared to previous year
SEPL’s operating revenue and profitability improved in FY2025(Prov.) as compared to FY2024, however, stood volatile over the past three years. The operating income improved to Rs.349.50 Cr. in FY2025(Prov.) as compared to Rs.301.95 Cr. in FY2024 and Rs.402.97 Cr. in FY2023. The operating profit margin also improved to 4.54% in FY2025 (Prov.) against 3.85% in FY2024 and 11.82% in FY2023. The PAT margin also improved marginally and stood at 3.03% in FY2025 (Prov.) against 2.43% in FY2024 and 8.11% in FY2023. The volatility in operating performance since FY2023 is primarily attributed to a decline in price realizations, driven by global demand and supply disruptions caused by dumping from China.

Healthy financial risk profile
SEPL’s financial risk profile  moderated in FY2025 (Prov.) however, overall remained healthy marked by healthy net worth, debt protection metrics, and below unity gearing. The net worth stood at Rs. 158.42 Cr. as on March 31, 2025 (Prov.), against Rs.152.64 Cr. as on March 31, 2024. The net worth has primarily improved on account of accretion of profits into reserves. The company also executed a share buyback amounting ~Rs.5.73 Cr. during the fiscal year 2025 . The gearing ratio stood  below unity at 0.21 times as on March 31, 2025 (Prov.), against 0.15 times as on March 31, 2024. The TOL/TNW stood at 0.97 times as on March 31, 2025 (Prov.), against 0.91 times as on March 31, 2024. Debt Coverage Ratios moderated in FY2025 (Prov.), however, remained healthy. Interest Coverage Ratio stood healthy at 10.32 times in FY2025 (Prov.) against 13.94 times in FY2024. DSCR stood at 4.92 times in FY2025 (Prov.) against 4.82 times in FY2024. Debt/EBITDA level stood at 1.67 times in FY2025 (Prov.) against 1.55 times in FY2024.

Acuite’ believes that financial risk profile of SEPL is expected to remain in similar lines over the medium term.


Weaknesses

­Working capital intensive operations
SEPL’s working capital operations are intensive in nature marked by GCA days of 221 days in FY2025 (Prov.) against 209 days in FY2024. The debtor days stood at 130 days in FY2025 (Prov.) against 116 days in FY2024. The inventory days stood at 65 days in FY2025 (Prov.) against 68 days in FY2024. The creditors days stood at 139 days in FY2025 (Prov.) against 150 days in FY2024. However, bank limit utilization for fund-based limits stood low at ~10.81% for the last 06 months ended May 25.

Acuite believes that working capital operations of the company may continue to remain intensive considering the nature of business.

Risks associated with agro-climatic fluctuations in the agro-chemicals sector
The company is a part of the seasonal agro-chemicals sector, which is closely correlated to the volume of agricultural activity in the nation and, in turn, directly dependent on the monsoons. The potential need for various agrochemicals, such as pesticides, insecticides etc. may be directly impacted by insufficient or untimely monsoons, which may have an effect on the production of some crops.

Rating Sensitivities
­
  • Sustained improvement in revenue and profitability while maintaining its credit profile.
  • Any further elongation in working capital cycle impacting its liquidity.
 
Liquidity Position
Adequate

SEPL generated sufficient cash accruals of Rs. 14.86 Cr. in FY2025 (Prov.) against repayment obligation of Rs.1.45 Cr. during the same period. It’s working capital operations are intensive marked by GCA days of 221 days in FY2025 (Prov.), however, the reliance on working capital limits stood low at ~10.81% for the last 06 months ended May 2025. The current ratio stood at 1.85 times as on March 31, 2025 (Prov.). SEPL maintained unencumbered cash and bank balance of Rs. 10.90 Cr. as on March 31, 2025 (Prov.).

Going ahead, the company is expected to generate healthy cash accruals in the range of Rs.14.84-16.69 Cr. against repayment obligation in the range of Rs.4.67-3.50 Cr. over the medium-term.

 
Outlook: Stable
­
 
Other Factors affecting Rating
­None
 

Particulars Unit FY 25 (Provisional) FY 24 (Actual)
Operating Income Rs. Cr. 349.50 301.95
PAT Rs. Cr. 10.60 7.32
PAT Margin (%) 3.03 2.43
Total Debt/Tangible Net Worth Times 0.21 0.15
PBDIT/Interest Times 10.32 13.94
Status of non-cooperation with previous CRA (if applicable)
­Not Applicable
 
Any other information
­None
 
Applicable Criteria
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm

Note on complexity levels of the rated instrument

Date Name of Instruments/Facilities Term Amount (Rs. Cr) Rating/Outlook
05 Apr 2024 Letter of Credit Short Term 40.00 ACUITE A2 (Reaffirmed)
Letter of Credit Short Term 22.00 ACUITE A2 (Reaffirmed)
Letter of Credit Short Term 44.00 ACUITE A2 (Reaffirmed)
Cash Credit Long Term 6.00 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
Cash Credit Long Term 8.00 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
Cash Credit Long Term 10.00 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
Term Loan Long Term 13.81 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
Term Loan Long Term 10.00 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
Proposed Long Term Loan Long Term 6.19 ACUITE BBB | Stable (Downgraded from ACUITE BBB+ | Stable)
11 Jan 2023 Letter of Credit Short Term 40.00 ACUITE A2 (Assigned)
Letter of Credit Short Term 22.00 ACUITE A2 (Assigned)
Letter of Credit Short Term 44.00 ACUITE A2 (Assigned)
Cash Credit Long Term 6.00 ACUITE BBB+ | Stable (Assigned)
Cash Credit Long Term 8.00 ACUITE BBB+ | Stable (Assigned)
Cash Credit Long Term 10.00 ACUITE BBB+ | Stable (Assigned)
Term Loan Long Term 20.00 ACUITE BBB+ | Stable (Assigned)
Term Loan Long Term 10.00 ACUITE BBB+ | Stable (Assigned)
­

Lender’s Name ISIN Facilities Date Of Issuance Coupon Rate Maturity Date Quantum
(Rs. Cr.)
Complexity Level Rating
DBS Bank Ltd Not avl. / Not appl. Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 6.00 Simple ACUITE BBB | Stable | Reaffirmed
CITI Bank Not avl. / Not appl. Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 8.00 Simple ACUITE BBB | Stable | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Cash Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 10.00 Simple ACUITE BBB | Stable | Reaffirmed
CITI Bank Not avl. / Not appl. Letter of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 22.00 Simple ACUITE A2 | Reaffirmed
DBS Bank Ltd Not avl. / Not appl. Letter of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 44.00 Simple ACUITE A2 | Reaffirmed
Yes Bank Ltd Not avl. / Not appl. Letter of Credit Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 40.00 Simple ACUITE A2 | Reaffirmed
Not Applicable Not avl. / Not appl. Proposed Long Term Loan Not avl. / Not appl. Not avl. / Not appl. Not avl. / Not appl. 6.19 Simple ACUITE BBB | Stable | Reaffirmed
CITI Bank Not avl. / Not appl. Term Loan Not avl. / Not appl. Not avl. / Not appl. 31 Mar 2030 13.81 Simple ACUITE BBB | Stable | Reaffirmed
CITI Bank Not avl. / Not appl. Term Loan Not avl. / Not appl. Not avl. / Not appl. 31 Mar 2030 10.00 Simple ACUITE BBB | Stable | Reaffirmed

Contacts

About Acuité Ratings & Research

© Acuité Ratings & Research Limited. All Rights Reserved.www.acuite.in